CD9 and Alzheimer disease: Nevertheless, we observed a significantly greater quantity of proteins CD9 and HSPG2 in the BDEVs of AD Braak V–VI patients, suggesting that some EVs could be enriched with CD9, which could reflect a redistribution of certain proteins at the late Braak stage (Fig. S5d–h).